Bupropion differentially impacts acquisition of methamphetamine self-administration and sucrose-maintained behavior

Carmela M. Reichel, Jessica D. Linkugel, Rick A Bevins

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Bupropion reduces the subjective effects and cue-induced craving for methamphetamine in humans. Given these effects of bupropion on methamphetamine in humans and its widespread clinical use, a preclinical model of drug-taking was used to determine if pretreatment with bupropion would alter the acquisition of methamphetamine self-administration. During acquisition, rats were given saline or bupropion (30 or 60 mg/kg, IP) 5 min before a 60-min session. For the first 8 days, each response on the active lever produced an infusion of methamphetamine (0.025 mg/kg). Responding on the inactive lever had no programmed consequence. This FR1 schedule was then increased to an FR3 for 4 more days. In a parallel study, the identical procedures were used to test the impact of bupropion on sucrose-maintained responding. Bupropion pretreatment decreased the number of methamphetamine infusions and sucrose deliveries earned on an FR1 and FR3. However, bupropion pretreatment only delayed discrimination between the active and inactive levers in the methamphetamine self-administration rats. Discrimination between active and inactive levers was acquired in all groups in the sucrose experiment regardless of pretreatment condition. Combined, these results suggest that bupropion has a more general effect within the appetitive/reward system of the brain rather than having complete specificity for methamphetamine.

Original languageEnglish (US)
Pages (from-to)463-472
Number of pages10
JournalPharmacology Biochemistry and Behavior
Volume89
Issue number3
DOIs
StatePublished - May 1 2008

Fingerprint

Bupropion
Self Administration
Methamphetamine
Sucrose
Rats
Reward
Cues
Brain
Appointments and Schedules

Keywords

  • Appetitive reinforcers
  • Conditioning
  • Drug-taking
  • Prevention
  • Wellbutrin
  • Zyban

ASJC Scopus subject areas

  • Biochemistry
  • Toxicology
  • Pharmacology
  • Clinical Biochemistry
  • Biological Psychiatry
  • Behavioral Neuroscience

Cite this

Bupropion differentially impacts acquisition of methamphetamine self-administration and sucrose-maintained behavior. / Reichel, Carmela M.; Linkugel, Jessica D.; Bevins, Rick A.

In: Pharmacology Biochemistry and Behavior, Vol. 89, No. 3, 01.05.2008, p. 463-472.

Research output: Contribution to journalArticle

@article{28b238313a6e43a79d4f293c942de84b,
title = "Bupropion differentially impacts acquisition of methamphetamine self-administration and sucrose-maintained behavior",
abstract = "Bupropion reduces the subjective effects and cue-induced craving for methamphetamine in humans. Given these effects of bupropion on methamphetamine in humans and its widespread clinical use, a preclinical model of drug-taking was used to determine if pretreatment with bupropion would alter the acquisition of methamphetamine self-administration. During acquisition, rats were given saline or bupropion (30 or 60 mg/kg, IP) 5 min before a 60-min session. For the first 8 days, each response on the active lever produced an infusion of methamphetamine (0.025 mg/kg). Responding on the inactive lever had no programmed consequence. This FR1 schedule was then increased to an FR3 for 4 more days. In a parallel study, the identical procedures were used to test the impact of bupropion on sucrose-maintained responding. Bupropion pretreatment decreased the number of methamphetamine infusions and sucrose deliveries earned on an FR1 and FR3. However, bupropion pretreatment only delayed discrimination between the active and inactive levers in the methamphetamine self-administration rats. Discrimination between active and inactive levers was acquired in all groups in the sucrose experiment regardless of pretreatment condition. Combined, these results suggest that bupropion has a more general effect within the appetitive/reward system of the brain rather than having complete specificity for methamphetamine.",
keywords = "Appetitive reinforcers, Conditioning, Drug-taking, Prevention, Wellbutrin, Zyban",
author = "Reichel, {Carmela M.} and Linkugel, {Jessica D.} and Bevins, {Rick A}",
year = "2008",
month = "5",
day = "1",
doi = "10.1016/j.pbb.2008.02.002",
language = "English (US)",
volume = "89",
pages = "463--472",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Bupropion differentially impacts acquisition of methamphetamine self-administration and sucrose-maintained behavior

AU - Reichel, Carmela M.

AU - Linkugel, Jessica D.

AU - Bevins, Rick A

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Bupropion reduces the subjective effects and cue-induced craving for methamphetamine in humans. Given these effects of bupropion on methamphetamine in humans and its widespread clinical use, a preclinical model of drug-taking was used to determine if pretreatment with bupropion would alter the acquisition of methamphetamine self-administration. During acquisition, rats were given saline or bupropion (30 or 60 mg/kg, IP) 5 min before a 60-min session. For the first 8 days, each response on the active lever produced an infusion of methamphetamine (0.025 mg/kg). Responding on the inactive lever had no programmed consequence. This FR1 schedule was then increased to an FR3 for 4 more days. In a parallel study, the identical procedures were used to test the impact of bupropion on sucrose-maintained responding. Bupropion pretreatment decreased the number of methamphetamine infusions and sucrose deliveries earned on an FR1 and FR3. However, bupropion pretreatment only delayed discrimination between the active and inactive levers in the methamphetamine self-administration rats. Discrimination between active and inactive levers was acquired in all groups in the sucrose experiment regardless of pretreatment condition. Combined, these results suggest that bupropion has a more general effect within the appetitive/reward system of the brain rather than having complete specificity for methamphetamine.

AB - Bupropion reduces the subjective effects and cue-induced craving for methamphetamine in humans. Given these effects of bupropion on methamphetamine in humans and its widespread clinical use, a preclinical model of drug-taking was used to determine if pretreatment with bupropion would alter the acquisition of methamphetamine self-administration. During acquisition, rats were given saline or bupropion (30 or 60 mg/kg, IP) 5 min before a 60-min session. For the first 8 days, each response on the active lever produced an infusion of methamphetamine (0.025 mg/kg). Responding on the inactive lever had no programmed consequence. This FR1 schedule was then increased to an FR3 for 4 more days. In a parallel study, the identical procedures were used to test the impact of bupropion on sucrose-maintained responding. Bupropion pretreatment decreased the number of methamphetamine infusions and sucrose deliveries earned on an FR1 and FR3. However, bupropion pretreatment only delayed discrimination between the active and inactive levers in the methamphetamine self-administration rats. Discrimination between active and inactive levers was acquired in all groups in the sucrose experiment regardless of pretreatment condition. Combined, these results suggest that bupropion has a more general effect within the appetitive/reward system of the brain rather than having complete specificity for methamphetamine.

KW - Appetitive reinforcers

KW - Conditioning

KW - Drug-taking

KW - Prevention

KW - Wellbutrin

KW - Zyban

UR - http://www.scopus.com/inward/record.url?scp=40849140472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40849140472&partnerID=8YFLogxK

U2 - 10.1016/j.pbb.2008.02.002

DO - 10.1016/j.pbb.2008.02.002

M3 - Article

VL - 89

SP - 463

EP - 472

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 3

ER -